Science & Enterprise subscription

Follow us on Twitter

  • New post on Science and Enterprise: Editorial Posts Resume Tomorrow https://t.co/ZTVMsYlwg8 #Science #Business
    about 6 hours ago
  • As mobile phones, smart watches, and tablets play an increasingly key role in our daily lives, a new report shows m… https://t.co/HNOl3qa4oI
    about 2 days ago
  • New post on Science and Enterprise: Infographic – Mobile Industry’s Economic Role https://t.co/aMBZtn0gkM #Science #Business
    about 2 days ago
  • FDA expert panel gives thumbs-up to Aimmune’s peanut allergy drug https://t.co/srCucGLuB5
    about 3 days ago
  • A developer of a drug for migraine formulated as a dry powder and given as a nasal spray is raising $82.5 million i… https://t.co/gn4NSNTmBR
    about 3 days ago

Please share Science & Enterprise

Gene-Editing Biotech Gains $34M in Early Funds

Sickle cell illustration

A two year-old enterprise spun-off from Yale University is developing gene-editing treatments for genetic disorders with synthetic peptides and DNA delivered in nanoscale particles. . . . → Read More: Gene-Editing Biotech Gains $34M in Early Funds

Stanford, Berkeley, MIT Top Undergrad Start-Up Ranking

Shop open sign

Stanford University, University of California in Berkeley, and Massachusetts Institute of Technology lead the undergraduate programs producing founders of start-up companies in 2019. . . . → Read More: Stanford, Berkeley, MIT Top Undergrad Start-Up Ranking

Aging Therapy Network Adds $100M to Venture Round

Hands on lap

An enterprise supporting a group of companies developing new drugs to address the aging process raised another $100 million in its second venture funding round. . . . → Read More: Aging Therapy Network Adds $100M to Venture Round

Infographic – A.I. Venture Deals Reach New Highs

AI funding chart

The total amount of venture capital worldwide raised by artificial intelligence start-up companies set a record in the second quarter of 2019, reaching $7.4 billion. . . . → Read More: Infographic – A.I. Venture Deals Reach New Highs

Food Technology Company Gains $4M in Seed Funds

Cut oranges and grapefruit

A company developing a food preservation technology from university materials science labs is raising $4 million in its seed funding round. . . . → Read More: Food Technology Company Gains $4M in Seed Funds

Infographic – U.S. Venture Funds Near 20-Year Highs

Venture investment chart

Total venture capital funding in the U.S. for first six months of 2019 reached levels not seen since the year 2000, the waning days of the dot-com era. . . . → Read More: Infographic – U.S. Venture Funds Near 20-Year Highs

Immunotherapy Biotech Gains $325M in Venture Funds

Investment graphic

A biotechnology enterprise developing personalized treatments for cancer and infectious diseases is raising $325 million in its second venture funding round. . . . → Read More: Immunotherapy Biotech Gains $325M in Venture Funds

Stem Cell Start-Up Raises $250M in Venture Funds

T-cell lymphocyte

A company begun last year to create cancer therapies from banked, off-the-shelf stem cells is raising $250 million in its first round of venture financing. . . . → Read More: Stem Cell Start-Up Raises $250M in Venture Funds

A.I. Chip Start-Up Raises $23M in Early Funds

A start-up enterprise is developing computer chips designed to run artificial intelligence, or A.I., applications but with an architecture it says can avoid memory logjams. . . . → Read More: A.I. Chip Start-Up Raises $23M in Early Funds

Company Launches Attacking Cancer Proteins, Lands $67M

Cancer magnified

A new enterprise is starting-up to develop treatments that target cancer-causing proteins considered unreachable with current therapies. . . . → Read More: Company Launches Attacking Cancer Proteins, Lands $67M